The Annonaceous acetogenin bullatacin is cytotoxic against multidrug-resistant human mammary adenocarcinoma cells

Cytotoxic effects of the Annonaceous acetogenin, bullatacin, were studied in multidrug-resistant (MDR) human mammary adenocarcinoma (MCF-7/Adr) cells vs. the parental non-resistant wild type (MCF-7/wt) cells. Bullatacin was effectively cytotoxic to the MCF-7/Adr cells while it was more cytostatic to...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer letters 1997-05, Vol.115 (1), p.73-79
Hauptverfasser: Oberlies, Nicholas H., Croy, Vicki L., Harrison, Marietta L., McLaughlin, Jerry L.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 79
container_issue 1
container_start_page 73
container_title Cancer letters
container_volume 115
creator Oberlies, Nicholas H.
Croy, Vicki L.
Harrison, Marietta L.
McLaughlin, Jerry L.
description Cytotoxic effects of the Annonaceous acetogenin, bullatacin, were studied in multidrug-resistant (MDR) human mammary adenocarcinoma (MCF-7/Adr) cells vs. the parental non-resistant wild type (MCF-7/wt) cells. Bullatacin was effectively cytotoxic to the MCF-7/Adr cells while it was more cytostatic to the MCF-7/wt cells. ATP depletion is the mode of action of the Annonaceous acetogenins, and these agents offer a special advantage in the chemotherapeutic treatment of MDR tumors that have ATP-dependent mechanisms.
doi_str_mv 10.1016/S0304-3835(97)04716-2
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78937694</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0304383597047162</els_id><sourcerecordid>78937694</sourcerecordid><originalsourceid>FETCH-LOGICAL-c502t-4f24aed53473ba770110c33676a3513887b8fcf4c9310627973f55c98d4fb5193</originalsourceid><addsrcrecordid>eNqFkEFPHSEQx0nTxj61H8GEg2nqYVtYYIGTMaa1TUx6qJ7JLMs-aXZBgTX125f1vbyrpyGZ3wz_-SF0RslXSmj37Q9hhDdMMfFFywvCJe2a9h3aUCXbRmpF3qPNAfmIjnP-SwgRXIojdKSJrgjdoKe7B4evQogBrItLxrWUuHXBB9wv0wQFbH36jO1LiSX-8xbDFnzIBc_LVPyQlm2TXPa5QCj4YZkh4BnmGdILhsGFaCHVFXEGbN005VP0YYQpu0_7eoLuf3y_u_7Z3P6--XV9ddtYQdrS8LHl4AbBuGQ9SEkoJZaxTnbABGVKyV6NduRWM0q6VmrJRiGsVgMfe0E1O0Gfd3sfU3xaXC5m9nlNAGE91Eilmew0r6DYgTbFnJMbzWPya3xDiVlVm1fVZvVotDSvqk1b5872Hyz97IbD1N5t7Z_v-5AtTGOCYH0-YG1HlZCkYpc7zFUZz94lk613wbrBJ2eLGaJ_I8h_4ZWcZQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78937694</pqid></control><display><type>article</type><title>The Annonaceous acetogenin bullatacin is cytotoxic against multidrug-resistant human mammary adenocarcinoma cells</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Oberlies, Nicholas H. ; Croy, Vicki L. ; Harrison, Marietta L. ; McLaughlin, Jerry L.</creator><creatorcontrib>Oberlies, Nicholas H. ; Croy, Vicki L. ; Harrison, Marietta L. ; McLaughlin, Jerry L.</creatorcontrib><description>Cytotoxic effects of the Annonaceous acetogenin, bullatacin, were studied in multidrug-resistant (MDR) human mammary adenocarcinoma (MCF-7/Adr) cells vs. the parental non-resistant wild type (MCF-7/wt) cells. Bullatacin was effectively cytotoxic to the MCF-7/Adr cells while it was more cytostatic to the MCF-7/wt cells. ATP depletion is the mode of action of the Annonaceous acetogenins, and these agents offer a special advantage in the chemotherapeutic treatment of MDR tumors that have ATP-dependent mechanisms.</description><identifier>ISSN: 0304-3835</identifier><identifier>EISSN: 1872-7980</identifier><identifier>DOI: 10.1016/S0304-3835(97)04716-2</identifier><identifier>PMID: 9097981</identifier><identifier>CODEN: CALEDQ</identifier><language>eng</language><publisher>Shannon: Elsevier Ireland Ltd</publisher><subject>Acetogenins ; Adenocarcinoma - drug therapy ; Adenosine Triphosphate - metabolism ; Antineoplastic agents ; Antineoplastic Agents, Phytogenic ; Biological and medical sciences ; Breast Neoplasms - drug therapy ; Bullatacin ; Cell Division - drug effects ; Chemotherapy ; Drug Resistance, Multiple ; Furans - pharmacology ; Humans ; Mammary adenocarcinoma ; Medical sciences ; Multidrug resistance ; P-gp ; Pharmacology. Drug treatments ; Tumor Cells, Cultured</subject><ispartof>Cancer letters, 1997-05, Vol.115 (1), p.73-79</ispartof><rights>1997</rights><rights>1997 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c502t-4f24aed53473ba770110c33676a3513887b8fcf4c9310627973f55c98d4fb5193</citedby><cites>FETCH-LOGICAL-c502t-4f24aed53473ba770110c33676a3513887b8fcf4c9310627973f55c98d4fb5193</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0304383597047162$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2618570$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9097981$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Oberlies, Nicholas H.</creatorcontrib><creatorcontrib>Croy, Vicki L.</creatorcontrib><creatorcontrib>Harrison, Marietta L.</creatorcontrib><creatorcontrib>McLaughlin, Jerry L.</creatorcontrib><title>The Annonaceous acetogenin bullatacin is cytotoxic against multidrug-resistant human mammary adenocarcinoma cells</title><title>Cancer letters</title><addtitle>Cancer Lett</addtitle><description>Cytotoxic effects of the Annonaceous acetogenin, bullatacin, were studied in multidrug-resistant (MDR) human mammary adenocarcinoma (MCF-7/Adr) cells vs. the parental non-resistant wild type (MCF-7/wt) cells. Bullatacin was effectively cytotoxic to the MCF-7/Adr cells while it was more cytostatic to the MCF-7/wt cells. ATP depletion is the mode of action of the Annonaceous acetogenins, and these agents offer a special advantage in the chemotherapeutic treatment of MDR tumors that have ATP-dependent mechanisms.</description><subject>Acetogenins</subject><subject>Adenocarcinoma - drug therapy</subject><subject>Adenosine Triphosphate - metabolism</subject><subject>Antineoplastic agents</subject><subject>Antineoplastic Agents, Phytogenic</subject><subject>Biological and medical sciences</subject><subject>Breast Neoplasms - drug therapy</subject><subject>Bullatacin</subject><subject>Cell Division - drug effects</subject><subject>Chemotherapy</subject><subject>Drug Resistance, Multiple</subject><subject>Furans - pharmacology</subject><subject>Humans</subject><subject>Mammary adenocarcinoma</subject><subject>Medical sciences</subject><subject>Multidrug resistance</subject><subject>P-gp</subject><subject>Pharmacology. Drug treatments</subject><subject>Tumor Cells, Cultured</subject><issn>0304-3835</issn><issn>1872-7980</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkEFPHSEQx0nTxj61H8GEg2nqYVtYYIGTMaa1TUx6qJ7JLMs-aXZBgTX125f1vbyrpyGZ3wz_-SF0RslXSmj37Q9hhDdMMfFFywvCJe2a9h3aUCXbRmpF3qPNAfmIjnP-SwgRXIojdKSJrgjdoKe7B4evQogBrItLxrWUuHXBB9wv0wQFbH36jO1LiSX-8xbDFnzIBc_LVPyQlm2TXPa5QCj4YZkh4BnmGdILhsGFaCHVFXEGbN005VP0YYQpu0_7eoLuf3y_u_7Z3P6--XV9ddtYQdrS8LHl4AbBuGQ9SEkoJZaxTnbABGVKyV6NduRWM0q6VmrJRiGsVgMfe0E1O0Gfd3sfU3xaXC5m9nlNAGE91Eilmew0r6DYgTbFnJMbzWPya3xDiVlVm1fVZvVotDSvqk1b5872Hyz97IbD1N5t7Z_v-5AtTGOCYH0-YG1HlZCkYpc7zFUZz94lk613wbrBJ2eLGaJ_I8h_4ZWcZQ</recordid><startdate>19970501</startdate><enddate>19970501</enddate><creator>Oberlies, Nicholas H.</creator><creator>Croy, Vicki L.</creator><creator>Harrison, Marietta L.</creator><creator>McLaughlin, Jerry L.</creator><general>Elsevier Ireland Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19970501</creationdate><title>The Annonaceous acetogenin bullatacin is cytotoxic against multidrug-resistant human mammary adenocarcinoma cells</title><author>Oberlies, Nicholas H. ; Croy, Vicki L. ; Harrison, Marietta L. ; McLaughlin, Jerry L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c502t-4f24aed53473ba770110c33676a3513887b8fcf4c9310627973f55c98d4fb5193</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Acetogenins</topic><topic>Adenocarcinoma - drug therapy</topic><topic>Adenosine Triphosphate - metabolism</topic><topic>Antineoplastic agents</topic><topic>Antineoplastic Agents, Phytogenic</topic><topic>Biological and medical sciences</topic><topic>Breast Neoplasms - drug therapy</topic><topic>Bullatacin</topic><topic>Cell Division - drug effects</topic><topic>Chemotherapy</topic><topic>Drug Resistance, Multiple</topic><topic>Furans - pharmacology</topic><topic>Humans</topic><topic>Mammary adenocarcinoma</topic><topic>Medical sciences</topic><topic>Multidrug resistance</topic><topic>P-gp</topic><topic>Pharmacology. Drug treatments</topic><topic>Tumor Cells, Cultured</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Oberlies, Nicholas H.</creatorcontrib><creatorcontrib>Croy, Vicki L.</creatorcontrib><creatorcontrib>Harrison, Marietta L.</creatorcontrib><creatorcontrib>McLaughlin, Jerry L.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Oberlies, Nicholas H.</au><au>Croy, Vicki L.</au><au>Harrison, Marietta L.</au><au>McLaughlin, Jerry L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Annonaceous acetogenin bullatacin is cytotoxic against multidrug-resistant human mammary adenocarcinoma cells</atitle><jtitle>Cancer letters</jtitle><addtitle>Cancer Lett</addtitle><date>1997-05-01</date><risdate>1997</risdate><volume>115</volume><issue>1</issue><spage>73</spage><epage>79</epage><pages>73-79</pages><issn>0304-3835</issn><eissn>1872-7980</eissn><coden>CALEDQ</coden><abstract>Cytotoxic effects of the Annonaceous acetogenin, bullatacin, were studied in multidrug-resistant (MDR) human mammary adenocarcinoma (MCF-7/Adr) cells vs. the parental non-resistant wild type (MCF-7/wt) cells. Bullatacin was effectively cytotoxic to the MCF-7/Adr cells while it was more cytostatic to the MCF-7/wt cells. ATP depletion is the mode of action of the Annonaceous acetogenins, and these agents offer a special advantage in the chemotherapeutic treatment of MDR tumors that have ATP-dependent mechanisms.</abstract><cop>Shannon</cop><pub>Elsevier Ireland Ltd</pub><pmid>9097981</pmid><doi>10.1016/S0304-3835(97)04716-2</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0304-3835
ispartof Cancer letters, 1997-05, Vol.115 (1), p.73-79
issn 0304-3835
1872-7980
language eng
recordid cdi_proquest_miscellaneous_78937694
source MEDLINE; Elsevier ScienceDirect Journals
subjects Acetogenins
Adenocarcinoma - drug therapy
Adenosine Triphosphate - metabolism
Antineoplastic agents
Antineoplastic Agents, Phytogenic
Biological and medical sciences
Breast Neoplasms - drug therapy
Bullatacin
Cell Division - drug effects
Chemotherapy
Drug Resistance, Multiple
Furans - pharmacology
Humans
Mammary adenocarcinoma
Medical sciences
Multidrug resistance
P-gp
Pharmacology. Drug treatments
Tumor Cells, Cultured
title The Annonaceous acetogenin bullatacin is cytotoxic against multidrug-resistant human mammary adenocarcinoma cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-15T13%3A06%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Annonaceous%20acetogenin%20bullatacin%20is%20cytotoxic%20against%20multidrug-resistant%20human%20mammary%20adenocarcinoma%20cells&rft.jtitle=Cancer%20letters&rft.au=Oberlies,%20Nicholas%20H.&rft.date=1997-05-01&rft.volume=115&rft.issue=1&rft.spage=73&rft.epage=79&rft.pages=73-79&rft.issn=0304-3835&rft.eissn=1872-7980&rft.coden=CALEDQ&rft_id=info:doi/10.1016/S0304-3835(97)04716-2&rft_dat=%3Cproquest_cross%3E78937694%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78937694&rft_id=info:pmid/9097981&rft_els_id=S0304383597047162&rfr_iscdi=true